about
Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategiesInfrequent p53 gene mutation but UV gradient-like p53 protein positivity in keloids.Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer.Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.Circulating tumor DNA as a liquid biopsy for cancer.Genetic and epigenetic analysis of putative breast cancer stem cell models.The dynamic range of circulating tumor DNA in metastatic breast cancerMultiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing.POLE mutations in families predisposed to cutaneous melanoma.Detection of Circulating Tumor DNA in the Blood of Cancer Patients: An Important Tool in Cancer Chemoprevention.Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing.High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis.Circulating tumor cells and DNA as liquid biopsies.Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis.Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsiesRapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.Hematogenous dissemination of glioblastoma multiforme.Depressed patients with incurable cancer: which depressive symptoms do they experience?Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA.Interviews with patients with advanced cancer--another step towards an international cancer pain classification system.Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.Polyclonality of multiple sporadic basal cell carcinomas.Single circulating tumor cell sequencing for monitoring.Preexisting TP53 mutation in therapy-related acute myeloid leukemia.The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type.Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.Co-occurrence of MYC amplification and TP53 mutations in human cancer.Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.Extra phenotypic features in a girl with Miller syndromeLysyl oxidase-like 2 promoter hypermethylation in mid-dermal elastolysisFacial dysmorphism associated with distinctive spine abnormalities in a girl and her motherp14ARF Hypermethylation Is Common but INK4a-ARF Locus or p53 Mutations Are Rare in Merkel Cell CarcinomaT1799A BRAF Mutation is Common in PUVA LentiginesHuman melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization
P50
Q33275985-4D242EB8-2DE7-44E2-B026-AD66F808E63CQ34195303-A48F2951-118D-49A1-B740-182DCDBA2A8CQ34322575-231C8A60-027E-42E7-BE39-60134F006A7FQ34427193-0AD33336-AD7E-4980-8345-B8D3365DC2FEQ34447436-910A9ABC-95E1-4E03-B903-4D843274256FQ34863513-9F2BDAF1-A86D-41C8-93B4-064B1B69D65CQ35000808-599D4329-83E0-44CE-B8B2-E672EF0A0B89Q35077001-358CC69A-71B1-4F36-916F-DADB21F3953BQ35133788-C976CB6D-792E-4E1D-A124-10C26F07C495Q35739446-3C14E892-9EB2-422F-94C5-B86FD0DD8A79Q35853245-59828F6F-2933-4ECF-8EC8-FE43743C2622Q36998629-77A77261-1648-4E68-A4B5-DC512C79177CQ37151097-17D02ABE-5D10-44C4-82FE-3383BBDB849EQ38133673-137F9333-6E44-4701-88B4-26194CB06768Q38414501-AC124037-952A-4095-B645-CF4ED3E6F58CQ38700222-74A1BD04-EBB0-407F-AE61-8BF1D5854BA1Q38884073-62946724-14EA-4586-905E-170037F6DBC0Q38969869-3964E8F2-D0F9-44B3-9148-247BC9B4E04CQ39471599-370C3155-AE19-4E32-A590-DA0919D7D20EQ39586205-7742A2DD-A9FC-4B7A-8508-6BD36D6CC987Q39663524-47AB1772-413C-4AD5-B694-BF1879F5771BQ41565184-65130B06-2F8D-4B5E-81D8-4408FAEE106FQ41868457-F89EA560-F724-4C86-A287-A9DD6ECEBADDQ42447524-BD3F6A20-7E26-4B77-81DE-E9A2D7AC8905Q42576747-859F6B74-9B0D-4B2C-8650-EC9891CFD27CQ43132538-5723129A-434D-4083-A185-C765F4DF8EF3Q43498648-730AB1BF-927B-45D5-BC50-292E598FB517Q44003528-ED2A8EDE-D2CB-4265-AF34-8A5E42B81D9CQ46302330-B23AA3A6-00E1-4AD8-95AD-E079B1185FA3Q48166295-3ACE8C78-91AB-4AC9-826D-C73A4647A2F1Q48179788-2A70C96D-F801-4D8A-BBF5-166C20572627Q48253543-CA34F9A4-A2E2-476B-AC99-22C86F362D48Q48292408-C69B6809-69D4-4154-B423-236B4EB6F06AQ54232902-571E4ADE-7985-42D9-8F83-BF2E7268BC3AQ57636593-64381500-BE69-49F3-B722-A229CEA003C6Q57637047-A96E3A0F-888D-4D53-B939-1761580D0837Q57637063-DDB7E713-50CF-4147-9B6E-22C48B772EA4Q57637070-EFB7824A-EB7F-4385-94D4-853F4AFA7DB8Q57637075-9AA9F464-2406-429B-BBB3-05CEE15B2E24Q64110013-045E8A98-D07C-4315-AEDB-B8A7290E2179
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ellen Heitzer
@ast
Ellen Heitzer
@en
Ellen Heitzer
@es
Ellen Heitzer
@nl
Ellen Heitzer
@sl
type
label
Ellen Heitzer
@ast
Ellen Heitzer
@en
Ellen Heitzer
@es
Ellen Heitzer
@nl
Ellen Heitzer
@sl
prefLabel
Ellen Heitzer
@ast
Ellen Heitzer
@en
Ellen Heitzer
@es
Ellen Heitzer
@nl
Ellen Heitzer
@sl
P1053
B-7354-2017
P106
P21
P31
P3829
P496
0000-0002-8815-7859